Enterprise cGMP & Botanical CDMO/CRO Standard

China Product Labeling Manufacturer & Manufacturers

Global Regulatory Labeling Engineering, Fingerprinted Analytical Substantiation, and High-Precision cGMP Contract Packaging Solutions for Pharmaceutical & Natural Botanical Formulations.

Analytical & Clinical Catalog

Validated CRO/CDMO Products & Certified Labeling Services

Precision-tested botanical entities, clinical trial dossiers, and cGMP labeling services backed by comprehensive HPLC/HPTLC analytical fingerprinting and end-to-end auditability.

ODM Clinic study Phase1 - Phase 4 Manufacturer, Suppliers
ODM Clinic Study (Phase 1 - Phase 4) Services

Investigational medicinal product (IMP) labeling, blinded trial coding, and regulatory clinical dossier documentation for global pharmaceutical submissions.

Explore Clinical Labeling
China Establishment of analysis methods of active ingredients Supplier, Suppliers
Establishment of Analysis Methods of Active Ingredients

Full analytical method validation (HPLC/GC/HPTLC) generating the quantitative chemical data required for compliant label claim substantiation.

Establish Testing Standards
China Screening of the active ingredient of plants Manufacturer
China Screening of Botanical Active Ingredients

Phytochemical screening, bio-fractionation, and phytochemical purity profiling supporting exact quantitative ingredient declarations.

Screen Active Ingredients
OEM Animal Study Supplier, Suppliers
OEM In Vivo Preclinical Animal Study Protocols

Toxicology panels, pharmacokinetics, and LD50 studies providing toxicological safety margins for pre-market health claim verification.

Commission Animal Studies
ODM Potency Evaluation by Seasons and Origins
Potency Evaluation by Seasonal & Origin Metrics

Origin-specific chromatographic evaluation ensuring geographic claim authentication, batch stability, and seasonal consistency.

Validate Raw Origins
OEM In Vitro Test Research Service Manufacturers, Suppliers
OEM In Vitro Cellular Assays & Research Services

Rapid mechanistic verification, receptor binding, and cellular pathway testing that substantiate biological efficacy claims on product labels.

Request In Vitro Data
Contract Manufacturing OEM for Active Ingredients
OEM Botanical Active Bulk Extraction & Drum Labeling

Standardized extracts in liquid, paste, volatile oils, and powders with serialized QR batch codes, tamper-evident drum closures, and full CoA tracking.

Order Bulk Formulations
CDMO Finished Dosage Form Product Labeling & Packaging
Finished Dosage Product Labeling & Packaging (CDMO)

Commercial blister packing, bottle labeling, barcoding, and secondary box packaging for softgels, capsules, tablets, and oral liquids.

Consult Packaging Specs
Strategic Framework

Macro-Level Industry Solutions in Product Labeling & Manufacturing

Re-engineering commercial labeling from simple graphic printing into an integrated scientific-regulatory architecture connecting raw plant genetics, chemical assay validation, and global commercial market entry.

In the modern global supply chain, partnering with a competent China product labeling manufacturer is no longer merely a packaging decision—it is a critical regulatory, scientific, and legal imperative. In regulated industries such as dietary supplements, botanical medicines, functional cosmetics, and Active Pharmaceutical Ingredients (APIs), the product label serves as the binding contract between the manufacturer, the distributor, the regulatory enforcement agency, and the final consumer. A single failure in chemical nomenclature, allergen disclosure, trace contaminant quantification, or batch-level traceability can trigger catastrophic customs detentions, FDA Warning Letters, product recalls, or complete market de-listing.
At MedGence (Yineng Pharma), headquartered in Changsha, Hunan, we have spent over 14 years bridging the gap between raw botanical discovery, laboratory validation, and commercial finished-product execution. With more than 300 in-house scientists and technicians, we treat product labeling as the culmination of an exhaustive research pipeline. Our contract manufacturing and labeling solutions span every dimension: from chromatographic fingerprint verification (confirming that what is printed on the label matches the exact milligram content in each capsule) to physical durability under extreme international transit conditions (anti-counterfeit holographic layering, moisture-barrier varnishes, cryogenic adhesive stability, and serialization).

Pharmacopeial Compliance Engineering

Cross-referencing active ingredient disclosures with the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Chinese Pharmacopoeia (ChP). We eliminate chemical ambiguity by standardizing marker naming, CAS registries, Latin binomial designations, and standardized extract concentration ratios (DER).

GS1-Compliant Digital Traceability

Deploying 2D DataMatrix codes, GS1 Digital Link barcodes, and serialized unique product identifiers (UDI) directly onto intermediate containers and retail boxes. This provides frictionless real-time customs clearance and gives consumers direct smartphone access to batch-specific Certificates of Analysis (CoA).

Multi-Layer Anti-Tampering & Security

Protecting intellectual property and brand prestige against grey-market counterfeiting through micro-text printing, UV-fluorescent dyes, holographic tear strips, tamper-evident neck bands, and tamper-indicating label substrate frangibility engineered to destroy upon removal.

Market Dynamics

Global Commercial & Industrial Landscape

Navigating complex international divergence: FDA 21 CFR Part 111, EU Food Information to Consumers (FIC), Health Canada NHP regulations, and China NMPA oversight.

The international labeling landscape is currently experiencing its most intense period of regulatory divergence in modern history. Brand owners, contract manufacturers, and private label importers must reconcile vastly conflicting geographic mandates:

North America (US FDA & Health Canada)

FDA 21 CFR Part 101 (Nutrition Labeling) and Part 111 (cGMP for Dietary Supplements) enforce strict guidelines on Supplement Facts panel structures, daily values (DVs), allergen declarations under FASTER Act (sesame inclusion), and structural/functional claim disclaimers. In Canada, Natural Health Product (NHP) licensing requires compliant Natural Product Numbers (NPN) and specific bilingual (English/French) display typography.

European Union (EMA & EFSA Framework)

Regulation (EU) No 1169/2011 mandates specific x-height font minimums (≥1.2 mm), explicit nutrient reference values (NRV), strict botanical substance warnings, and stringent limitations on health claims under Regulation (EC) 1924/2006. Furthermore, herbal medicinal products require Traditional Herbal Medicinal Product (THMPD) registration labels with authorized safety monographs.

Asia-Pacific & Domestic Chinese Standards

China National Medical Products Administration (NMPA) and State Administration for Market Regulation (SAMR) enforce the iconic "Blue Hat" certification for health foods, demanding exact functional claims, standard Chinese production license numbers (SC), and strict allergen warnings. Our dual-capability facilities support multi-market compliance across APAC, ASEAN, and ANZ region standards.

Authoritative Track Record

Institutional E-E-A-T Scale: 14+ Years of Proven Industry Leadership

Documented empirical results achieved for China’s foremost pharmaceutical conglomerates, university teaching hospitals, and clinical research institutions.

True authority in contract labeling and manufacturing is not earned through marketing claims—it is validated through rigorous audits, clinical achievements, and sustained industrial partnerships. At MedGence (Yineng Pharma), our scientific core has achieved milestones that few contract manufacturers globally can match:
14+
Years Dedicated R&D
300+
Senior Research Scientists
100+
Pharma Groups & Hospitals
83
Classic TCM Formulas Modernized
22
Innovative Natural Drugs
56
Hospital Drug Registrations
~400
Single-Herb Standards Built
100%
Audit Traceability Guarantee

Enterprise Supply Chain Partners & Hospital Clinical Affiliations

Beijing Tongrentang Group
China Resources Sanjiu (CR Sanjiu)
Sunflower Pharmaceutical Group
Livzon Pharmaceutical Group
Dihon Pharmaceutical Group
Golden Throat Holdings
Yangtzi River Pharmaceutical
Beihai Gofar Chuanshan Bio
Humanwell Healthcare Group
SCIMYTH Pharmaceutical Group
Shandong Hanfang Pharma
Luoxin Pharmaceutical Group
Guangdong Zhongsheng Pharma
Hunan Brilliance & Abundance
Apeloa Pharmaceutical
Hunan Heng Chang Pharma
Baotou Traditional Chinese Medicine
Kamp Medicine Co., Ltd.
Guangxi Santo Pharmaceutical
Hunan Kangshou Pharmaceutical
Jiangxi Juwang Pharmaceutical
Beijing Tcmages Pharmaceutical
Guizhou Ruihe Pharmaceutical
Anhui CR Jinchan Pharma
Kangmei Pharmaceutical
Hunan Tianjicaotang Pharma
Jiangxi Kingstone Unite Pharma
Shuguang Hospital (Shanghai TCM)
Hunan Province Directly Affiliated Hospital
First Hospital of Hunan Univ TCM
2nd Xiangya Hospital Central South Univ
Second Hospital of Hunan Univ TCM
Zhuzhou City Orthopedics TCM
Precision Operations

Localization Support & Complete Compliance Assurance

From microclimate harvest variance to multi-language dossier localization, we guarantee that label statements are backed by indisputable chemical and physical data.

Multilingual Regulatory Dossier Mapping

Cross-border labeling requires more than translation; it necessitates legal localization. We translate Latin pharmacopeial taxonomy into French, German, Spanish, Japanese, and Arabic, ensuring localized statutory warning text, allergen bolding, and local importer information meet target customs border demands flawlessly.

Geographic Origin & Terroir Fingerprinting

Botanical active potency shifts dramatically depending on seasonal solar exposure, soil chemistry, and harvesting altitude. Our analytical laboratories run HPLC and HPTLC fingerprinting across multiple harvesting seasons, verifying that claims like "High Potency Ginsenoside" or "Standardized Salicin" correspond to genuine chemical concentration.

Full Non-Disclosure & IP Ring-Fencing

We operate on a strict entrusted contract research model. Your patented formulas, proprietary extraction ratios, novel active delivery platforms, and specialized packaging designs are legally insulated under binding international non-disclosure agreements (NDAs) to permanently prevent formula leakage.

Sector Solutions

Specialized Industrial Application Scenarios

Targeted engineering for oral supplements, pharmaceutical investigational products, hospital clinical preparations, and high-performance functional cosmetics.

Nutraceutical & Functional Foods

High-speed roll-fed pressure-sensitive labeling for bottle packaging (HDPE, PET, glass), pouch serialization, and tamper-evident blister cartons. Calibrated for gummies, softgels, hard capsules, and effervescent granules with full shelf-life stability against moisture and light degradation.

Pharmaceutical IMPs & Clinical Trials

Double-blind clinical trial kit labeling, multi-language booklet labels (extended-content peel-and-reveal labels), randomized patient kit coding, and randomized serialization compliant with Good Clinical Practice (GCP) and FDA 21 CFR Part 312 guidelines.

Hospital Preparations & Formulations

Supporting registered clinical formulations across our network of 56 hospital preparations. Batch-specific barcoded ampoules, oral liquid unit doses, and sterile topical formulations adhering to strictly enforced inpatient administration tracing and NMPA medical audits.

Clean-Label Cosmeceuticals & Personal Care

Chemical-resistant, oil-resistant synthetic film labeling (BOPP, PE, PET) for dropper bottles, cosmetic serum pumps, and aluminum tubes. High-resolution metallic foil stamping and spot-UV varnishing designed to withstand oily active residues without print bleeding.

Innovation Trajectory

Technological Roadmap & Future Outlook

Pioneering the convergence of AI visual inspection, near-field communication (NFC), and sustainable circular materials in contract manufacturing.

Phase 1: Present

AI Vision Verification & OCR Quality Gates

Integrating high-speed 360-degree optical cameras with deep learning optical character recognition (OCR) directly on manufacturing lines. 100% of labels are inspected in real time for missing lot numbers, unreadable 2D codes, or skewed alignment at 400 units/min.

Phase 2: Horizon 2026

GS1 Digital Link & Dynamic Cloud Dossiers

Transitioning global product lines from legacy 1D barcodes to multi-dimensional GS1 Digital Link QR codes. One single on-pack code routes consumers to branded interactive portals while granting customs authorities access to batch certificates of analysis.

Phase 3: Horizon 2027

NFC/RFID Embedded Cold-Chain Integrity

Deploying printed ultra-thin NFC sensors directly onto intermediate clinical trial and biologics packaging to record ambient temperature excursions, assuring biological stability before therapeutic administration.

Phase 4: Horizon 2028+

100% Biodegradable & Ocean-Safe Substrates

Developing next-generation wood-free stone paper, agricultural residue fibers, and marine-degradable adhesive matrices that decouple pharmaceutical labeling from petrochemical polymers without sacrificing moisture barrier properties.

Procurement Intelligence

Frequently Asked Questions from Global Procurement Officers

Direct answers covering minimum order quantities, regulatory auditing, IP defense, analytical validation, and lead times.

What distinguishes a scientific CDMO like MedGence from commercial print shops?
A commercial print shop merely applies ink to paper without understanding or testing the contents inside. MedGence (Yineng Pharma) is an established Contract Research Organization (CRO) and Contract Development & Manufacturing Organization (CDMO). We operate validated HPLC, GC, and HPTLC testing laboratories, pilot extraction facilities, and cleanrooms. We do not just print labels; we scientifically validate that the chemical constituents inside the bottle match the active claims, verify heavy metal and pesticide thresholds, manage clinical trials, and guarantee that the final packaging meets the statutory regulations of the target export market (US FDA, Health Canada, EU EMA, or China NMPA).
How does your team guarantee that our proprietary formula and IP remain confidential?
We work strictly under bilateral Non-Disclosure and Entrusted Manufacturing Agreements enforceable under international law. In our pilot plant and collaborative facilities, production runs are compartmentalized using numerical code designations rather than commercial brand names. Your formulations, specific botanical extraction parameters, chromatography profiles, and final packaging files are stored on isolated, encrypted servers with multi-tier access control. Over 14+ years and across 100+ pharmaceutical partnerships, our operational IP record remains entirely uncompromised.
Which specific analytical tools are deployed to substantiate label claims?
Depending on your product formulation, we establish and run High-Performance Liquid Chromatography (HPLC) for precise compound quantification, High-Performance Thin-Layer Chromatography (HPTLC) for botanical species identity authentication, Gas Chromatography (GC) for volatile components and residual solvents, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metals, and LC-MS/MS for multi-residue pesticide screens. Every commercial packaging run is accompanied by a formal Certificate of Analysis (CoA) tied directly to the container's batch number.
Can MedGence support small-scale trial batches as well as commercial high-volume packaging?
Yes. Our facilities are designed with an agile two-tier architecture. In our pilot and clinical trial department, we support pilot batches, hospital preparation scale-ups (56 registrations achieved), and clinical investigational trials (Phase I to Phase IV) with smaller minimum runs. When you transition to commercial rollout, our collaborative full-scale cGMP packaging lines can produce millions of units monthly across oral liquids, hard capsules, softgels, tablets, and powders.
How do you handle multi-market export labeling with conflicting statutory requirements?
Our regulatory affairs team conducts an initial gap analysis between your source formulation and the destination market's statutory requirements. We design multi-language peel-and-reveal booklet labels, customized secondary packaging, or separate SKU variants optimized for specific regional regulations (e.g., dual English/French panels for Health Canada, Nutrition/Supplement Facts formats for the US FDA, and specific metric x-height font standards for the EU).
What are the typical project turnaround timelines from initial brief to shipment?
For existing, validated formulations requiring contract manufacturing and custom labeling, standard production and packaging turnaround is typically 4 to 6 weeks from label proof sign-off and raw ingredient release. If your project requires novel analytical method development, seasonal botanical potency evaluation, stability testing, or clinical efficacy substantiate dossiers, project timelines range from 8 to 16 weeks depending on study duration and regulatory complexity.
Manufacturing & Study Re-Order

Contract CDMO Capabilities & Validated Research Catalog

Select a specific research protocol, analytical method establishment, or commercial dosage form packaging run to initiate your production cycle.

ODM Clinic study Phase1 - Phase 4 Manufacturer, Suppliers
Phase I - IV Clinical Study Dossier & IMP Labeling

End-to-end clinical trial support, multi-language blinding labels, and statistical health claim documentation for international regulatory review.

Configure Clinical Program
China Establishment of analysis methods of active ingredients Supplier, Suppliers
Analysis Method Establishment (HPLC / HPTLC / GC)

Developing and validating quantitative assay standards to substantiate exact concentration declarations on consumer retail labels.

Develop Method SOP
China Screening of the active ingredient of plants Manufacturer
Botanical Active Ingredient Bio-Screening

Targeted phytochemical discovery matching specific bio-activities with sustainable raw botanical species and high-density cultivars.

Initiate Screening
OEM Animal Study Supplier, Suppliers
Preclinical Animal Safety & Toxicology Trials

Acute, sub-chronic, and genotoxicity evaluation providing robust preclinical safety margins required for statutory warning panels.

Request Toxicology Study
ODM Potency Evaluation by Seasons and Origins
Seasonal & Geographic Potency Standardization

Quantifying regional bio-compound variances across harvests to establish reliable baseline potency claims across multi-year supply contracts.

Audit Origin Data
OEM In Vitro Test Research Service Manufacturers, Suppliers
In Vitro Cellular Efficacy Assays

Cell culture screening across antioxidant, metabolic, and anti-inflammatory markers to provide scientifically verifiable claims for marketing labels.

Access In Vitro Data
Contract Manufacturing OEM for Active Ingredients
Bulk API & Botanical Extract CDMO Production

Industrial pilot and bulk extraction of high-purity powders, pastes, and concentrated liquids with full serialization and Drum UDI codes.

Request Extraction Quote
CDMO Finished Dosage Form Product Labeling & Packaging
Full Turnkey CDMO Finished Dosage Packaging

Automated blister sealing, high-speed bottle labeling, serialization, and master shipping case packaging for tablets, capsules, and liquids.

Schedule Production Run
Direct Scientific Consultation

Engage Our Senior Chemical & Regulatory Team

Send your formulation specifications, target international markets, and packaging design requirements directly to our chief scientists in Changsha, Hunan.

Email: [email protected] | Location: Room 101, Building 1, No. 31 Qianfutang Rd, Yuelu District, Changsha, China
Initiate Project Brief Visit CDMO Facility